Kidney Transplantation

• 

  Subject Areas on Research

  • "Keyhole" method for accelerating imaging of contrast agent uptake. 
  • 10-year survey of referrals to a pediatric nephrology program. 
  • 1982 resident's essay award: the immunologic effects of lymphoid irradiation in human and non-human primates: cellular changes and the potential for renal transplantation. 
  • 1990 ARRS Executive Council Award. Renal transplant rejection: diagnosis with 31P MR spectroscopy. 
  • 4D11: The Second Mouse? 
  • De Novo Renal Cell Carcinoma of Native Kidneys in Renal Transplant Recipients: A Single-center Experience. 
  • A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort study. 
  • A Cascade of Structural Barriers Contributing to Racial Kidney Transplant Inequities. 
  • A GPS for finding the route to transplantation for the sensitized patient. 
  • A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. 
  • A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation. 
  • A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. 
  • A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation. 
  • A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation. 
  • A comparison of deprivation indices and application to transplant populations. 
  • A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal. 
  • A comparison of the sensitivities of contrast and isotope voiding cystourethrograms for the detection of pancreas transplant bladder leaks. 
  • A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients. 
  • A decade of minimally invasive donation: experience with more than 1200 laparoscopic donor nephrectomies at a single institution. 
  • A forgotten vascular technique in renal transplantation. 
  • A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award. 
  • A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant. 
  • A novel approach to the treatment of chronic allograft nephropathy. 
  • A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation. 
  • A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. 
  • A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. 
  • A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation. 
  • A quantitative histomorphometric comparison of 40 micron thick Paragon sections with 5 micron thick Goldner sections in the study of undecalcified bone. 
  • A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. 
  • A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation. 
  • A role for leukotrienes in cyclosporine nephrotoxicity. 
  • A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. 
  • ACR Appropriateness Criteria® Renal Transplant Dysfunction. 
  • AI Methods in Bioethics. 
  • APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. 
  • APOL1: a case in point for replacing race with genetics. 
  • Abdominal complications in organ transplant recipients. 
  • Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection. 
  • Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. 
  • Acquired cytomegalovirus retinitis. Four new cases and a review of the literature with implications for management. 
  • Acute Kidney Injury in a Patient With a Kidney Transplant and Posttransplant Lymphoproliferative Disorder: A Quiz. 
  • Acute kidney transplant failure following transurethral bladder polyp fulguration. 
  • Acute promyelocytic leukemia following solid organ transplantation. 
  • Acute renal allograft rejection: difficulty in diagnosis of histologically mild cases by MR imaging. 
  • Addition of an endothelin receptor antagonist to modified Belzer's perfusion preservation solution mitigates the adverse effect of preretrieval warm ischemic injury on posttransplant glomerular filtration rate. 
  • Addressing racial and ethnic disparities in live donor kidney transplantation: priorities for research and intervention. 
  • Addressing the challenges of sleeve gastrectomy in end-stage renal disease: Analysis of 100 consecutive renal failure patients. 
  • Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. 
  • Affective psychoses following renal transplant. 
  • African Americans' discussions about living-donor kidney transplants with family or friends: Who, what, and why not? 
  • Age and comorbidities are effect modifiers of gender disparities in renal transplantation. 
  • Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus-positive kidney transplant recipient. 
  • Age-related effects on thymic output and homeostatic T cell expansion following depletional induction in renal transplant recipients. 
  • Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial. 
  • Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. 
  • Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. 
  • Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. 
  • Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. 
  • Alimentary tract complications after renal transplantation. 
  • Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. 
  • Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. 
  • Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts. 
  • Amphotericin B therapy in an anephric patient. 
  • An age-independent gene signature for monitoring acute rejection in kidney transplantation. 
  • An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation. 
  • An uncommon cause of acutely altered mental status in a renal transplant recipient. 
  • An uncommon presentation of non-Hodgkin's lymphoma in a renal transplant recipient. 
  • Analysis of early readmissions after combined pancreas-kidney transplantation. 
  • Analysis of injury in complex organ preservation. 
  • Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. 
  • Aneurysms in abdominal organ transplant recipients. 
  • Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation. 
  • Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. 
  • Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies. 
  • Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection. 
  • Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection. 
  • Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology. 
  • Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. 
  • Antibody-mediated rejection--an ounce of prevention is worth a pound of cure. 
  • Antioxidant lazaroid U-74006F improves renal function and reduces the expression of cytokines, inducible nitric oxide synthase, and MHC antigens in a syngeneic renal transplant model. Partial support for the response-to-injury hypothesis. 
  • Antioxidant nutrients protect against cyclosporine A nephrotoxicity. 
  • Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. 
  • Apparent recurrence of progressive systemic sclerosis in a renal allograft. 
  • Application of a Novel CT-Based Iliac Artery Calcification Scoring System for Predicting Renal Transplant Outcomes. 
  • Applying the WHO conceptual framework for the International Classification for Patient Safety to a surgical population. 
  • Assessment of cadaveric organ viability during pulsatile perfusion using infrared imaging. 
  • Assessment of living renal donors with spiral CT. 
  • Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014. 
  • Association of Serious Fall Injuries among United States End Stage Kidney Disease Patients with Access to Kidney Transplantation. 
  • Association of Social Risk Factors With Home Dialysis and Kidney Transplant Rates in Dialysis Facilities. 
  • Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts. 
  • Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. 
  • Association of serum phosphorus level with anemia in kidney transplant recipients. 
  • Associations between rat renal allograft function, inflammation, and host immunity. 
  • Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients. 
  • Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients. 
  • Associations of perceived information adequacy and knowledge with pursuit of live donor kidney transplants and living donor inquiries among African American transplant candidates. 
  • Atheroembolic involvement of renal allografts. 
  • Attitudes of patients with renal disease on xenotransplantation: A systematic review. 
  • Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab. 
  • B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen. 
  • B cells and transplantation tolerance. 
  • B lymphocytes differentially influence acute and chronic allograft rejection in mice. 
  • BAFF is increased in renal transplant patients following treatment with alemtuzumab. 
  • BK virus and SV40 co-infection in polyomavirus nephropathy. 
  • BK virus-associated urinary bladder carcinoma in transplant recipients: productive or nonproductive polyomavirus infections in tumor cells? 
  • BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial. 
  • Banff 2011 Meeting report: new concepts in antibody-mediated rejection. 
  • Banff Digital Pathology Working Group: Going digital in transplant pathology. 
  • Bartonella henselae: etiology of pulmonary nodules in a patient with depressed cell-mediated immunity. 
  • Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function. 
  • Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. 
  • Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. 
  • Beyond histology: novel tools to diagnose allograft dysfunction. 
  • Bilateral native nephrectomy improves renal isograft function in rats. 
  • Bilateral nephrectomy by the posterior approach. 
  • Bilateral retroperitoneal renal allografts: technique for placement through a midline incision. 
  • Biomarkers for kidney transplant rejection. 
  • Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. 
  • Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function. 
  • Burden of early hospitalization after simultaneous liver-kidney transplantation: Results from the US Multicenter SLKT Consortium. 
  • C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates. 
  • CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation. 
  • CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. 
  • CD3-positive diffuse large B-cell lymphoma relapses as CD3-negative large B-cell lymphoma: Loss of aberrant antigen expression in B-cell lymphoma after chemotherapy. 
  • CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. 
  • CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection. 
  • CO2 angiography--a technique for vascular imaging in renal allograft dysfunction. 
  • CT evaluation of the renal donor and recipient. 
  • CT volumetry is superior to nuclear renography for prediction of residual kidney function in living donors. 
  • CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. 
  • Cadaver renal transplantation ignoring peak-reactive sera in patients with markedly decreasing pretransplant sensitization. 
  • Cadaveric renal transplantation in the cyclosporine and OKT3 eras: an update of the University of Wisconsin-Madison experience. 
  • Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells. 
  • Campath-1H in renal transplantation: The University of Wisconsin experience. 
  • Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. 
  • Campath-1H use in pediatric renal transplantation. 
  • Candida fasciitis following renal transplantation. 
  • Captopril and renal insufficiency. 
  • Cardiovascular mechanism of donor brain death and heart recipient survival. 
  • Case report. Steroid exophthalmos. 
  • Casting a smaller net into a bigger donor pool: A single center's experience with the new kidney allocation system. 
  • Causes of death in renal transplant recipients. A review of autopsy findings from 1966 through 1985. 
  • Cecal volvulus following laparoscopic nephrectomy and renal transplantation. 
  • Cellular immunology markers postransplantation predictive of long-term graft outcome. 
  • Center variations in patient selection for simultaneous heart-kidney transplantation. 
  • Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes. 
  • Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. 
  • Changing spectrum of pediatric renal transplantation. 
  • Characterization of Leu777Pro and Ile865Thr type IIA von Willebrand disease mutations. 
  • Characterization of T cells expressing the gamma/delta antigen receptor in human renal allografts. 
  • Chemokines and their receptors in human renal allotransplantation. 
  • Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. 
  • Choices in kidney transplantation in type 1 diabetes: are there skeletal benefits of the endocrine pancreas? 
  • Chronic kidney disease after hematopoietic cell transplantation: a systematic review. 
  • Chronic organizing microangiopathy in a renal transplant recipient. 
  • Chronic rejection of mouse kidney allografts. 
  • Chronic thromboxane inhibition preserves function of rejecting rat renal allografts. 
  • Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. 
  • Circulating donor antigen and response to donor antigen as predictors of long-term lung and kidney transplant success. 
  • Class II alloantibody and mortality in simultaneous liver-kidney transplantation. 
  • Clinical Outcomes of Older Kidney Transplant Recipients. 
  • Clinical and pathologic features of familial focal segmental glomerulosclerosis. 
  • Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection. 
  • Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis. 
  • Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. 
  • Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. 
  • Clinical pancreas preservation and transplantation. 
  • Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. 
  • Clinical problem-solving. Index of suspicion. 
  • Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document. 
  • Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood. 
  • Clinical significance of eosinophils in suspicious or borderline renal allograft biopsies. 
  • Clinically stable human renal allografts contain histological and RNA-based findings that correlate with deteriorating graft function. 
  • Clostridium difficile infection among kidney transplant recipients: frequency, clinical presentation, and outcome. 
  • Coats' disease in a renal transplant recipient. 
  • Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation. 
  • Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. 
  • Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. 
  • Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts. 
  • Comparison of ferumoxytol-enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosis. 
  • Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. 
  • Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. 
  • Complement-mediated vasoconstriction and graft rejection. 
  • Complement-targeted therapies in kidney transplantation-insights from preclinical studies. 
  • Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for ex vivo delivery. 
  • Complications of total hip arthroplasty following solid organ transplantation. 
  • Concerns regarding the financial aspects of kidney transplantation: perspectives of pre-transplant patients and their family members. 
  • Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplant Consortium Joint Working Committees on Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents: Part 2-Focus on Ascites, Fluid and Electrolytes, Renal, and Transfusion Issues. 
  • Controlled non-heart-beating donors: a potential source of extrarenal organs. 
  • Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation. 
  • Coping strategies utilized by adolescents with end stage renal disease 
  • Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. 
  • Correlation of preoperative imaging characteristics with donor outcomes and operative difficulty in laparoscopic donor nephrectomy. 
  • Correlations of test skin grafts and renal allograft function in human subjects genotyped for HL-A. 
  • Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantation. 
  • Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. 
  • Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. 
  • Custom, Contract, and Kidney Exchange 
  • Cutaneous squamous cell carcinoma with zosteriform metastasis in a transplant recipient. 
  • Cyclosporine therapy and the development of interstitial fibrosis in renal allografts. 
  • Cytokine genotypes in kidney, heart, and lung recipients: consequences for acute and chronic rejection. 
  • Cytokine kinetics profiling in pediatric renal transplant recipients. 
  • Cytomegaloviral infection presenting as a solitary pulmonary nodule. 
  • Daratumumab Use Prior to Kidney Transplant and T Cell-Mediated Rejection: A Case Report. 
  • Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use. 
  • De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years. 
  • Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. 
  • Declining influence of race on the outcome of living-donor renal transplantation. 
  • Decreased graft loss following implementation of the kidney allocation score (KAS). 
  • Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. 
  • Definition and Analysis of Textbook Outcome: A Novel Quality Measure in Kidney Transplantation. 
  • Delayed autotransplantation of a solitary kidney facilitated by pump perfusion preservation. 
  • Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation. 
  • Delayed vs initial cytomegalovirus prophylaxis after kidney transplantation. 
  • Depression in primary caregivers of patients listed for liver or kidney transplantation. 
  • Desensitization and belatacept-based maintenance therapy in pregnancy-sensitized monkeys receiving a kidney transplant. 
  • Detection of BK polyomavirus after kidney transplantation: a comparison of urine electron microscopy with plasma polymerase chain reaction. 
  • Detection of Donor's HIV Strain in HIV-Positive Kidney-Transplant Recipient. 
  • Detection of medical errors in kidney transplantation: a pilot study comparing proactive clinician debriefings to a hospital-wide incident reporting system. 
  • Detection of renal allograft rejection by computer 
  • Determinants of graft survival after renal transplantation. 
  • Determinants of the source of cytomegalovirus in murine renal allograft recipients. 
  • Development and future deployment of a 5 years allograft survival model for kidney transplantation. 
  • Development of a Telehealth Intervention to Improve Access to Live Donor Kidney Transplantation. 
  • Development of tolerogenic strategies in the clinic. 
  • Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients. 
  • Diagnosis and treatment of symptomatic peripancreatic fluid collections after pancreas transplant. 
  • Diagnostic tools for monitoring kidney transplant recipients. 
  • Dialysis Facility Profit Status and Early Steps in Kidney Transplantation in the Southeastern United States. 
  • Dialysis facility referral and start of evaluation for kidney transplantation among patients treated with dialysis in the Southeastern United States. 
  • Dialysis or transplantation: fitting the treatment to the patient. 
  • Diarrhea in a Patient With Combined Kidney-Pancreas Transplant. 
  • Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. 
  • Differential effects of donor-specific alloantibody. 
  • Differential regulation of calcineurin isoforms in transplant patients: a new look at an old problem. 
  • Differential regulation of leucocyte L-selectin (CD62L) expression in normal lymphoid and inflamed extralymphoid tissues. 
  • Disparities in the burden, outcomes, and care of chronic kidney disease. 
  • Dissecting the human kidney allograft transcriptome: single-cell RNA sequencing. 
  • Disseminated Adenovirus Infection After Combined Liver-Kidney Transplantation. 
  • Disseminated Mycobacterium immunogenum infection presenting with septic shock and skin lesions in a renal transplant recipient. 
  • Disseminated aspergillosis in a renal transplant patient: Diagnostic difficulties re-emphasized. 
  • Disseminated infection with rapidly growing mycobacteria. 
  • Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. 
  • Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. 
  • Donation after cardiac death: the University of Wisconsin experience. 
  • Donation after cardiac death: the university of wisconsin experience with renal transplantation. 
  • Donor derived HSV hepatitis in a kidney transplant recipient leading to liver fibrosis and portal hypertension. 
  • Donor factors affecting outcome after pancreas transplantation. 
  • Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. 
  • Donor kidney volume measured by computed tomography is a strong predictor of recipient eGFR in living donor kidney transplantation. 
  • Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. 
  • Donor risk index predicts graft failure reliably but not post-transplant infections. 
  • Donor-Derived Neuroendocrine Carcinoma Transmission to Two Kidney Transplant Recipients Demonstrated by Short Tandem Repeat Analysis: A Case Report. 
  • Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. 
  • Donor-origin cancer in renal transplant recipients from deceased donors: worth gambling? 
  • Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction. 
  • Double renal allografts successfully increase utilization of kidneys from older donors within a single organ procurement organization. 
  • Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts. 
  • Dual Kidney Allocation Score: A Novel Algorithm Utilizing Expanded Donor Criteria for the Allocation of Dual Kidneys in Adults. 
  • Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients. 
  • Early Postoperative Emergency Department Care of Abdominal Transplant Recipients. 
  • Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. 
  • Early experience with COVID-19 in kidney transplantation. 
  • Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymph. 
  • Effect of cyclosporin pharmacokinetics on renal allograft outcome in African-Americans. 
  • Effect of dietary fish oil supplementation on eicosanoid production by rat renal allografts. 
  • Effect of donor factors on early graft survival in adult cadaveric renal transplantation. 
  • Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients. 
  • Effectiveness of educational and social worker interventions to activate patients' discussion and pursuit of preemptive living donor kidney transplantation: a randomized controlled trial. 
  • Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients. 
  • Effects of DR mismatch on long-term graft survival in simultaneous kidney-pancreas transplantation. 
  • Effects of Ideal Versus Total Body Weight Dosage of Rabbit Antithymocyte Globulin on Outcomes of Kidney Transplant Patients With High Immunologic Risk. 
  • Effects of Sofosbuvir-Based Hepatitis C Treatment Regimens on Calcineurin Inhibitor Dosing in Liver and Kidney Transplant Recipients. 
  • Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation. 
  • Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model. 
  • Effects of leukocyte depleted blood on renal reperfusion injury in a porcine model. 
  • Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity. 
  • Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. 
  • Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation. 
  • Electron microscopic virus-like material in systemic lupus erythematosus: with preliminary immunologic observations on presence of measles antigen. 
  • Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Deceased Donors With Diabetes Mellitus: A National Analysis. 
  • Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. 
  • Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. 
  • Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization. 
  • Endothelial cell antibodies associated with novel targets and increased rejection. 
  • Endothelin receptor blockade during hypothermic perfusion preservation mitigates the adverse effect of preretrieval warm ischemic injury on posttransplant glomerular filtration rate. 
  • Endothelin-receptor blockade mitigates the adverse effect of preretrieval warm ischemia on posttransplantation renal function in rats. 
  • Endovascular stenting of the abdominal aorta following renal transplantation. 
  • Enteric conversion of bladder-drained pancreas allografts: experience in 95 patients. 
  • Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation. 
  • Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular analysis of 29 tumors from 19 patients. 
  • Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. 
  • Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer. 
  • Evaluation of Weight-Based Dose During Transition From Immediate-Release to Extended-Release Tacrolimus in Kidney Transplant Recipients. 
  • Evaluation of recurrent glomerulonephritis in kidney allografts. 
  • Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events. 
  • Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. 
  • Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. 
  • Exfoliative cytopathologic studies in organ transplantation IV. The cytologic diagnosis of herpesvirus in the urine of renal allograft recipients. 
  • Exfoliative cytopathologic studies in organ transplantation. 3. The cytologic profile of urine during acute renal allograft rejection. 
  • Exfoliative cytopathologic studies in organ transplantation. I. The cytologic diagnosis of cytomegalic inclusion disease in the urine of renal allograft recipients. 
  • Exfoliative cytopathologic studies in organ transplantation. V. The diagnosis of rejection in the immediate postoperative period. 
  • Expanded criteria donors/high risk recipients is not always cheaper than hemodialysis. 
  • Expanding the use of hepatitis C-viremic kidney donors. 
  • Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. 
  • Experience with 500 simultaneous pancreas-kidney transplants. 
  • Experience with combined hepatic, pancreaticoduodenal, and renal procurement with UW solution. 
  • Experience with enteric conversion after pancreas transplantation with bladder drainage. 
  • Experience with pancreas retransplantation. 
  • Experimental modeling of desensitization: What have we learned about preventing AMR? 
  • FK 506 induction and rescue therapy in pancreas transplant recipients. 
  • FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. 
  • Factors associated with cardiovascular events after simultaneous liver-kidney transplant from the US Multicenter Simultaneous Liver-Kidney Transplant Consortium. 
  • Factors associated with failure to list HIV-positive kidney transplant candidates. 
  • Familial hypocalciuric hypercalcemia in the donor and recipient of a living related donor kidney transplant. 
  • Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice. 
  • Fatal Apophysomyces elegans infection transmitted by deceased donor renal allografts. 
  • Fatal SV40-associated pneumonia and nephropathy following renal allotransplantation in rhesus macaque. 
  • Fatal and nonfatal hemorrhagic complications of living kidney donation. 
  • Fate of four cadaveric donor renal allografts with mesangial IgA deposits. 
  • Feasibility and acceptability of the TALK social worker intervention to improve live kidney transplantation. 
  • Feasibility of renal transplantation in systemic lupus erythematosus. 
  • Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. 
  • Finding the right job for the tool: alemtuzumab and its role in renal transplantation. 
  • Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. 
  • Foot problems in the diabetic transplant recipient. 
  • Fournier's gangrene: a complication of penile prosthetic implantation in a renal transplant patient. 
  • Frailty and Postkidney Transplant Health-Related Quality of Life. 
  • Frontiers in nephrology: immune tolerance to allografts in humans. 
  • Functional Characteristics and Phenotypic Plasticity of CD57+PD1- CD4 T Cells and Their Relationship with Transplant Immunosuppression. 
  • Functional role of thromboxane production by acutely rejecting renal allografts in rats. 
  • Functionally significant renal allograft rejection is defined by transcriptional criteria. 
  • Fungal infection following renal transplantation. 
  • Gastrointestinal complications of renal transplantation. 
  • Genetic determinants of renal transplant outcome: where do we stand? 
  • Genetic testing in nephrotic syndrome--challenges and opportunities. 
  • Genotypic diversity and clinical outcome of cryptococcosis in renal transplant recipients in Brazil. 
  • Graft Kidney Torsion After Simultaneous Kidney-Pancreas Transplant: Report of 2 Cases and Literature Review. 
  • Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. 
  • Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids. 
  • HIV in the dialysis population: Current issues and future directions. 
  • HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study. 
  • Half-life analysis of pancreas and kidney transplants. 
  • Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions. 
  • Helical CT of potential living renal donors: toward a greater understanding. 
  • Hematopoietic chimerism achieved by in utero hematopoietic stem cell injection does not induce donor-specific tolerance for renal allografts in sheep. 
  • Hemolytic anemia is not a frequent complication of ABO unmatched renal allografts from living related donors. 
  • Hemorrhagic Herpes Simplex Virus Type 1 Nephritis: An Unusual Cause of Acute Allograft Dysfunction. 
  • Heparan sulfate is a plasma biomarker of acute cellular allograft rejection. 
  • Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. 
  • Hepatitis E virus infection and rejection in kidney transplant recipients. 
  • Herpes simplex virus hepatitis after renal transplantation. 
  • High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept. 
  • High clinical suspicion of donor-derived disease leads to timely recognition and early intervention to treat solid organ transplant-transmitted lymphocytic choriomeningitis virus. 
  • Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies. 
  • Holmium:yttrium-aluminum-garnet laser endoureterotomy for the treatment of transplant kidney ureteral strictures. 
  • Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. 
  • Horseshoe kidney transplantation. 
  • Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. 
  • Hospitalizations for bacterial septicemia after renal transplantation in the united states. 
  • Hospitalizations for fractures after renal transplantation in the United States. 
  • How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation? 
  • Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. 
  • Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner. 
  • Human interleukin-2 and lymphoproliferative (T-helper cell) responses to soluble HLA class I antigens in vitro: I. Specificity for polymorphic domains. 
  • Human renal allograft rejection despite the absence of allogeneic passenger leukocytes. 
  • Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates. 
  • Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs. 
  • Hyperglycaemia associated with lactic acidaemia in a renal allograft recipient with type I glycogen storage disease. 
  • Hyperkalemia associated with intravenous labetalol therapy for acute hypertension in renal transplant recipients. 
  • Hyperlipidemia and transplantation: etiologic factors and therapy. 
  • IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. 
  • IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection. 
  • Identification of a B cell signature associated with renal transplant tolerance in humans. 
  • Identification of poorly performing transplant centers using the UNOS center-specific data. 
  • Identifying and addressing barriers to African American and non-African American families' discussions about preemptive living related kidney transplantation. 
  • Idiopathic intracranial hypertension following kidney transplantation: a case report and review of the literature. 
  • Ileocolonic perforation. A complication following renal transplantation. 
  • Iliac artery pseudoaneurysm following renal transplantation presenting as lumbosacral plexopathy. 
  • Immune profiling: molecular monitoring in renal transplantation. 
  • Immune reconstitution syndrome in a patient with disseminated histoplasmosis and steroid taper: maintaining the perfect balance. 
  • Immune status assay (ISA): a noninvasive procedure for studying allograft rejection. 
  • Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. 
  • Immunogenetics of consanguineous allografts in man. II. Correlation of renal allografting with HL-A genotyping. 
  • Immunologic mechanisms of transplant rejection. 
  • Immunologic risks of combined kidney-pancreas transplantation. 
  • Immunological mechanisms of allograft rejection. 
  • Immunological studies on eluates from human renal allografts. 
  • Immunoregulation and tolerance. 
  • Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading? 
  • Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. 
  • Impact of Covid-19 on kidney transplant and waiting list patients: Lessons from the first wave of the pandemic. 
  • Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System. 
  • Impact of Medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation. 
  • Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases. 
  • Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation. 
  • Impaired muscle oxygen metabolism in uremic children: improved after renal transplantation. 
  • Improved renal function in mouse kidney allografts lacking MHC class I antigens. 
  • Improving Access to Kidney Transplantation: Business as Usual or New Ways of Doing Business? 
  • In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplantation in monkeys. 
  • In vitro and in vivo human T cell repertoire in kidney allograft rejection. 
  • Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium. 
  • Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience. 
  • Incidence and risk factors of incisional hernia formation following abdominal organ transplantation. 
  • Incidence of anatomical variants in renal vasculature in the presence of normal renal function. 
  • Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary? 
  • Incidental detection of nutcracker phenomenon on multidetector CT in an asymptomatic population: prevalence and associated findings. 
  • Incidental fibromuscular dysplasia in potential renal donors: long-term clinical follow-up. 
  • Incisional Infections after Renal Transplant: Outcome Data From 238 Consecutive Recipients. 
  • Increased beta 2-microglobulin (B2M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD). 
  • Increased glomerular deposits of von Willebrand factor in chronic, but not acute, rejection of primate renal allografts. 
  • Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. 
  • Increased living donor volunteer rates with a formal recipient family education program. 
  • Increased risk of pulmonary edema in diabetic patients undergoing preemptive pancreas transplantation with OKT3 induction. 
  • Indications and techniques for renal, pancreas, and liver transplantation. 
  • Inducing unresponsiveness by the use of anti-CD3 immunotoxin, CTLA4-Ig, and anti-CD40 ligand. 
  • Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. 
  • Infection prophylaxis in pancreas transplant recipients. 
  • Infections after kidney transplantation. Does age matter? 
  • Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study. 
  • Infections after upper extremity allotransplantation: a worldwide population cohort study, 1998-2017. 
  • Influence of changes in pretransplant sensitization on patient and graft survival in cadaver renal transplantation. 
  • Influence of long chain polyunsaturated fatty acids and ornithine concentrations on complications after renal transplant. 
  • Inhibition of αvβ6 promotes acute renal allograft rejection in nonhuman primates. 
  • Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation. 
  • Initial nonfunction in cadaveric renal transplantation. 
  • Innate networking: Thrombotic microangiopathy, the activation of coagulation and complement in the sensitized kidney transplant recipient. 
  • Interleukin-15 receptor blockade in non-human primate kidney transplantation. 
  • Intestinal Perforation in Renal Transplant Recipients: A Single Center Experience of 2123 Recipients. 
  • Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression. 
  • Intravenous digital subtraction angiography in the evaluation of potential renal donors. 
  • Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. 
  • Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies. 
  • Is there a transfusion effect in combined pancreas-kidney transplantation? 
  • Kidney Xenotransplantation: Steps toward Clinical Application. 
  • Kidney allograft survival of African American and Caucasian American recipients with lupus. 
  • Kidney and pancreas transplantation at Wake Forest University Baptist Medical Center. 
  • Kidney transplant candidates' views of the transplant allocation system. 
  • Kidney transplant in the COVID era: Cautious optimism and continued vigilance. 
  • Kidney transplant practice patterns and outcome benchmarks over 30 years: The 2018 report of the NAPRTCS. 
  • Kidney transplant recipients infected by COVID-19: Review of the initial published experience. 
  • Kidney transplantation after sleeve gastrectomy in the morbidly obese candidate: results of a 2-year experience. 
  • Kidney transplantation in HIV-infected patients. 
  • Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up. 
  • Kidney transplantation using living donors. 
  • Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy. 
  • Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. 
  • Lambda light chain deposition disease in a renal allograft. 
  • Laparoscopic donor nephrectomy with a 23-hour stay: a new standard for transplantation surgery. 
  • Laparoscopic kidney donation: looking more than skin deep. 
  • Laparoscopic living donor nephrectomy and multiple renal arteries. 
  • Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients. 
  • Laparoscopic versus open donor nephrectomy: comparing ureteral complications in the recipients and improving the laparoscopic technique. 
  • Late coexistent acute cellular and antibody-mediated rejection in non-sensitized renal transplant patients. 
  • Late first acute rejection in pediatric kidney transplantation: A North American Pediatric Renal Trials and Collaborative Studies special study. 
  • Late withdrawal of cyclosporine in stable renal transplant recipients. 
  • Leflunomide for polyomavirus type BK nephropathy. 
  • Leontiasis ossea in secondary hyperparathyroidism. 
  • Letter by Moris et al Regarding Article, "Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients". 
  • Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. 
  • Limited health literacy and adverse outcomes among kidney transplant candidates. 
  • Lithiasis of the renal allograft, a rare urological complication following renal transplantation: a single-center experience of 2,045 renal transplantations. 
  • Living related and unrelated donors for kidney transplantation. A 28-year experience. 
  • Living unrelated kidney donation: an underutilized resource? 
  • Living unrelated renal donation: the University of Wisconsin experience. 
  • Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure? 
  • Living-unrelated renal donor transplantation: the UNOS experience, 1987-1991. United Network for Organ Sharing. 
  • Living-unrelated renal transplantation at the University of Wisconsin. 
  • Living-unrelated renal transplantation at the University of Wisconsin. 
  • Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients. 
  • Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy. 
  • Long-term outcome of simultaneous kidney-pancreas transplantation: analysis of 61 patients with more than 5 years follow-up. 
  • Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy. 
  • Long-term outcomes in simultaneous kidney-pancreas transplant recipients. 
  • Long-term outcomes in simultaneous kidney-pancreas transplantation. 
  • Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned. 
  • Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients. 
  • Long-term results with forty-five living related renal allograft recipients genotypically identical for HLA. 
  • Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry. 
  • Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. 
  • Losartan in post-transplant erythrocytosis. 
  • Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function. 
  • MR imaging of renal transplants. 
  • Machine perfusion of donor kidneys may reduce graft rejection. 
  • Making the Case for Reproductive Counseling in Liver Transplant Care. 
  • Malnutrition and immune cell subsets in children undergoing kidney transplantation. 
  • Massive gastrointestinal hemorrhage due to rupture of a donor pancreatic artery pseudoaneurysm in a pancreas transplant patient. 
  • Measuring and explaining racial and ethnic differences in willingness to donate live kidneys in the United States. 
  • Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. 
  • Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model. 
  • Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation. 
  • Membranoproliferative glomerulonephritis. Progression from the pure form to the crescentic form with recurrence after transplantation. 
  • Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. 
  • Meteorology and tolerance. 
  • Methemoglobinemia associated with dapsone treatment in solid organ transplant recipients: a two-case report and review. 
  • Methods to prevent rejection of homografts in man: a report on living related kidney donor selection by HL-A genotyping. 
  • Methyldopa therapy and outcome in cadaveric renal transplantation. 
  • Microchimerism in sensitized renal patients. 
  • Microvascular Disease After Renal Transplantation. 
  • Microvascular inflammation in renal allograft biopsies assessed by endothelial and leukocyte co-immunostain: a retrospective study on reproducibility and clinical/prognostic correlates. 
  • Miles to go…. 
  • Mispredicting and misremembering: patients with renal failure overestimate improvements in quality of life after a kidney transplant. 
  • Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. 
  • Molecular evaluation of BK polyomavirus nephropathy. 
  • Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. 
  • Monitoring renal transplants: An application of the multi-process Kalman filter 
  • Monocyte infiltration and kidney allograft dysfunction during acute rejection. 
  • Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. 
  • Multicenter data to improve health for pediatric renal transplant recipients in North America: Complementary approaches of NAPRTCS and IROC. 
  • Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. 
  • Multiple bilateral oncocytomas of the native kidneys following renal transplantation: report of a rare case and review of the literature. 
  • Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody. 
  • Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. 
  • Murine cytomegalovirus dissemination but not reactivation in donor-positive/recipient-negative allogeneic kidney transplantation can be effectively prevented by transplant immune tolerance. 
  • Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients. 
  • Mycotic aneurysm of the thoracoabdominal aorta in a child with end-stage renal disease. 
  • Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate. 
  • Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. 
  • Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model. 
  • Neutropenic enterocolitis (typhlitis) in a pediatric renal transplant patient. A case report and review of the literature. 
  • New developments in geriatric surgery. 
  • No change in complication rate using spring-loaded gun compared to traditional percutaneous renal allograft biopsy techniques. 
  • Non-invasive monitoring of tissue oxygenation during laparoscopic donor nephrectomy. 
  • Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. 
  • Nontraditional sites for vascular anastomoses to enable kidney transplantation in patients with major systemic venous thromboses. 
  • Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial. 
  • Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. 
  • OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation. 
  • Obesity as a risk factor following renal transplantation. 
  • Obesity following kidney transplantation and steroid avoidance immunosuppression. 
  • Objective, real-time, intraoperative assessment of renal perfusion using infrared imaging. 
  • Ocular pathology of Fabry's disease in a hemizygous male following renal transplantation. 
  • Of ends and means. 
  • Of mice and women: do sex-dependent responses to ischemia-reperfusion injury in rodents have implications for delayed graft function in humans? 
  • Offering more without offering compensation: non-compensating benefits for living kidney donors. 
  • Oliguria. A sign of renal success or impending renal failure? 
  • Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients. 
  • Organ allocation for transplantation in the USA and Korea: the changing roles of equity and utility. 
  • Organ donation and treatment of the multi-organ donor. 
  • Organ trafficking: global solutions for a global problem. 
  • Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. 
  • Orthopedic complications of renal transplantation in children. 
  • Orthostatic acute renal failure in a renal transplant. 
  • Outcome after splenic vein thrombosis in the pancreas allograft. 
  • Outcome in recipients of dual kidney transplants: an analysis of the dual registry patients. 
  • Outcomes after pediatric kidney transplantation improving: how can we do even better? 
  • Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. 
  • Outcomes in Kidney Transplantation Between Veterans Affairs and Civilian Hospitals: Considerations in the Context of the MISSION Act. 
  • Outcomes in kidney transplant recipients from older living donors. 
  • Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system. 
  • Outcomes of endovascular interventions for salvage of renal transplant allografts. 
  • Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. 
  • Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae. 
  • Paediatric renal transplantation: a single centre study. 
  • Pancreas transplantation at the University of Maryland. 
  • Pancreas transplantation at the University of Wisconsin. 
  • Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association. 
  • Pancreas transplantation: the Nebraska experience. 
  • Pediatric chronic kidney disease in North Carolina. 
  • Peptic ulcer disease following renal transplantation. 
  • Perceived Susceptibility to Chronic Kidney Disease and Hypertension Self-Management among Black and White Live Kidney Donors. 
  • Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations. 
  • Perforation of the gastrointestinal tract following renal transplantation. 
  • Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication? 
  • Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. 
  • Peripheral vascular disease and renal transplant artery stenosis: a reappraisal of transplant renovascular disease. 
  • Pharmaceutical expenses after kidney and kidney-pancreas transplantation. 
  • Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipients. 
  • Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients. 
  • Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection. 
  • Pharmacological approaches to antibody-mediated rejection-Are we getting closer? 
  • Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes. 
  • Phenotype and function of T cells propagated from donor-specific blood transfusion enhanced and autologous blood transfused rejecting rat renal allografts. 
  • Physical Crossmatching vs Virtual Crossmatching: The end of an era? or Why give up a good thing? 
  • Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. 
  • Plasma cells and acute rejection of a near-total face transplant: an incidental finding or an evolving plasma-cell-mediated rejection? 
  • Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. 
  • Platelet-derived CD154: ultrastructural localization and clinical correlation in organ transplantation. 
  • Pneumocystis carinii pneumonia in renal transplant recipients. 
  • Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation. 
  • Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy. 
  • Portal venous donor-specific transfusion in conjunction with sirolimus prolongs renal allograft survival in nonhuman primates. 
  • Post transplant CD8+ gammadelta T-cell lymphoma associated with human herpes virus-6 infection. 
  • Post transplant erythrocytosis in hypercalcemic renal transplant recipients. 
  • Post-Traumatic Stress Disorder and Post-Traumatic Growth following Kidney Transplantation. 
  • Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. 
  • Post-transplant hypertension in the rat: effects of captopril and native nephrectomy. 
  • Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? 
  • Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). 
  • Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients. 
  • Postinfectious glomerulonephritis in renal allograft recipients. 
  • Postoperative Impact of Diabetes, Chronic Kidney Disease, Hemodialysis, and Renal Transplant After Total Hip Arthroplasty. 
  • Posttransplant diastolic hypertension: associations with intragraft transforming growth factor-beta, endothelin, and renin transcription. 
  • Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. 
  • Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis. 
  • Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation. 
  • Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested? 
  • Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates. 
  • Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study. 
  • Predictive Factors of Renal Adaptation After Nephrectomy in Kidney Donors. 
  • Predictive factors for immunologic graft failure in cadaver renal transplant recipients. 
  • Predictors of low estimated glomerular filtration rate after living kidney donation in a Southeast Asian population from Singapore. 
  • Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families. 
  • Pregnancy in a patient with Goodpasture syndrome and renal transplantation. 
  • Preliminary assessment of safety and adherence to a once-daily immunosuppression regimen in kidney transplantation: Results of a randomized controlled pilot study. 
  • Preoperative Echocardiographic Differences and Transplant Outcomes Among Patients Receiving Simultaneous Liver-Kidney Versus Liver Transplant Alone. 
  • Preoperative evaluation of potential renal donors using multidetector CT. 
  • Preservation of the cadaveric kidney for transplantation. 
  • Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients. 
  • Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity. 
  • Preventing bone loss after renal transplantation with bisphosphonates: we can... but should we? 
  • Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: a rare presentation of a posttransplant lymphoproliferative disorder. 
  • Primary graft dysfunction and health-related quality of life after transplantation: The good, the bad, and the missing. 
  • Primary hyperoxaluria. 
  • Primate renal transplants using immunotoxin. 
  • Procurement, preservation, and transport of cadaver kidneys. 
  • Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies. 
  • Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. 
  • Proteinuria in pediatric renal transplant recipients during the first 60 post-transplant days. 
  • Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. 
  • Protocol of a randomized controlled trial of culturally sensitive interventions to improve African Americans' and non-African Americans' early, shared, and informed consideration of live kidney transplantation: the Talking About Live Kidney Donation (TALK) Study. 
  • Protocol of the KTFT-TALK study to reduce racial disparities in kidney transplant evaluation and living donor kidney transplantation. 
  • Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. 
  • Proton-decoupled phosphorus-31 magnetic resonance spectroscopy in the evaluation of native and well-functioning transplanted kidneys. 
  • Psychological distress and associated factors among kidney transplant recipients and living kidney donors during COVID-19. 
  • Public preferences for efficiency and racial equity in kidney transplant allocation decisions. 
  • Pulmonary mucormycosis: radiologic findings in 32 cases. 
  • Quantifying renal allograft loss following early antibody-mediated rejection. 
  • Quantifying the risk of incompatible kidney transplantation: a multicenter study. 
  • Quantitative evaluation of acute renal transplant dysfunction with low-dose three-dimensional MR renography. 
  • Radiation therapy for renal transplant rejection refractory to pulse steroids and OKT3. 
  • Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. 
  • Re: Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent. 
  • Reasons why kidneys removed for transplantation are not transplanted in the United States. 
  • Receipt and Sharing of Information to Improve Knowledge About Living Donor Kidney Transplant among Transplant Candidates with Advanced Chronic Kidney Disease. 
  • Recent History of Serious Fall Injuries and Posttransplant Outcomes Among US Kidney Transplant Recipients. 
  • Recent advances in immunosuppressive therapy for prevention of renal allograft rejection. 
  • Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection. 
  • Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group. 
  • Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. 
  • Reduced Racial Disparity in Kidney Transplant Outcomes in the United States from 1990 to 2012. 
  • Referral and Evaluation for Kidney Transplantation Following Implementation of the 2014 National Kidney Allocation System. 
  • Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. 
  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials. 
  • Rejection of kidney allografts by MHC class I-deficient mice. 
  • Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation. 
  • Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation. 
  • Relationships among renal allograft biopsy infiltrates, growth of T cell lines, and irreversible rejection. 
  • Renal Function Variability: An Independent Risk Factor for Graft Loss and Death following Kidney Transplantation. 
  • Renal Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US Multicenter Simultaneous Liver-Kidney Transplantation Consortium. 
  • Renal Recovery Years After Initial Diagnosis of Hemolytic Uremic Syndrome. 
  • Renal Transplantation with grafts affected by tumors: learning from a 'near miss' case. 
  • Renal actions of RGS2 control blood pressure. 
  • Renal allograft cell infiltrates associated with irreversible rejection. 
  • Renal allograft rejection: evaluation by Doppler US and MR imaging. 
  • Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance. 
  • Renal allografts in HL-A matched recipients. Light, immunofluorescence and electron microscopic studies. 
  • Renal autotransplants in sheep: investigation of renal function and renovascular hypertension. 
  • Renal cell carcinoma suspected at time of organ donation 2008-2016: A report of the OPTN ad hoc Disease Transmission Advisory Committee Registry. 
  • Renal epithelial cell-derived monocyte colony stimulating factor as a local informant of renal injury and means of monocyte activation. 
  • Renal function with cyclosporine C2 monitoring, enteric-coated mycophenolate sodium and basiliximab: a 12-month randomized trial in renal transplant recipients. 
  • Renal magnetic resonance angiography in the preoperative detection of supernumerary renal arteries in potential kidney donors. 
  • Renal paratransplant hernia revealed: a review of the literature. 
  • Renal paratransplant hernia. An uncommon variant of internal hernia. Are we aware of it? 
  • Renal response following perioperative ketorolac analgesia in living kidney donation. 
  • Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent. 
  • Renal transplantation at the University of Wisconsin in the cyclosporine era. 
  • Renal transplantation between HL-A haploidentical donor-recipient pairs: functional and morphological evaluation. 
  • Renal transplantation between HL-A identical donor-recipient pairs. Functional and morphological evaluation. 
  • Renal transplantation between histocompatible donor-recipient pairs. 
  • Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome. 
  • Renal transplantation in children. 
  • Renal transplantation in the American black. 
  • Renal transplantation in the cyclosporine era. 
  • Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. 
  • Renal tubular cell expression of MHC class II (I-Eb) is insufficient to initiate immune injury in a transgenic kidney transplant model. 
  • Renin-angiotensin system gene expression in post-transplant hypertension predicts allograft function. 
  • Rescue thrombolysis: resolution of intraglomerular thrombi after donation after circulatory death. 
  • Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. 
  • Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). 
  • Results of solitary pancreas transplantation with enteric drainage: is there a benefit from monitoring urinary amylase levels? 
  • Results of the South-Eastern Organ Procurement Foundation strategy for transplanting sensitized patients. 
  • Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. 
  • Retransplantation in the diabetic patient with a pancreas allograft. 
  • Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant. 
  • Retroperitoneal compartment syndrome after renal transplantation. 
  • Retroperitoneal renal and intraperitoneal pancreatic transplantation. 
  • Reversal of acute allograft rejection using immunotoxin. 
  • Reversible cardiomyopathies--a review. 
  • Review of the use of hepatitis B core antibody-positive kidney donors. 
  • Risk factors for BK polyomavirus nephritis in renal allograft recipients. 
  • Risk factors for renal allograft loss in patients with systemic lupus erythematosus. 
  • Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry. 
  • Risk factors in necrotizing fasciitis: a case involving Cryptococcus neoformans. 
  • Risk of Infective Endocarditis in Patients with End Stage Renal Disease. 
  • Risk versus reward: total joint arthroplasty outcomes after various solid organ transplantations. 
  • Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension. 
  • Role of low-dose calcineurin inhibitor regimens in pediatric kidney transplantation. 
  • Role of platelet activating factor in kidney transplant rejection in the rat. 
  • SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? 
  • Safety and feasibility of renal blood flow determination during kidney transplant surgery with perfusion ultrasonography. 
  • Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipients. 
  • Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial. 
  • Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study. 
  • Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts. 
  • Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study. 
  • Selection of donors for kidney transplantation. 
  • Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model. 
  • Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. 
  • Sensitivity and specificity of a monitoring test. 
  • Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report. 
  • Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study. 
  • Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort. 
  • Sex and Gender Differences in Kidney Transplantation. 
  • Sex and gender disparity in kidney transplantation: Historical and future perspectives. 
  • Shifting Clinical Trial Endpoints in Kidney Transplantation: The Rise of Composite Endpoints and Machine Learning to Refine Prognostication. 
  • Shortening a Carrel Patch in a Graft With Multiple Arteries: A Step-By-Step Technical Analysis. 
  • Significance of cytokine gene polymorphism in renal transplantation. 
  • Significance of the Banff borderline biopsy. 
  • Similarities in long-term alloreactive T cell lines propagated from transfusion-enhanced and control-rejecting rat renal allografts. 
  • Simultaneous kidney transplantation and bilateral native nephrectomy for polycystic kidney disease. 
  • Simultaneous kidney-pancreas transplantation at the University of Wisconsin. 
  • Simultaneous pancreas-kidney (SPK) transplantation from controlled non-heart-beating donors (NHBDs). 
  • Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? 
  • Simultaneous pancreas-kidney transplantation at University of Wisconsin-Madison Hospital. 
  • Simultaneous pancreas-kidney transplantation at the University of Wisconsin. 
  • Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. 
  • Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. 
  • Simultaneous pancreas/kidney transplantation--a comparison of enteric and bladder drainage of exocrine pancreatic secretions. 
  • Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection. 
  • Single-center analysis of infectious complications in older adults during the first year after kidney transplantation. 
  • Single-center experience with renal transplantation in patients with Wegener's granulomatosis. 
  • Single-site laparoscopic living donor nephrectomy offers comparable perioperative outcomes to conventional laparoscopic living donor nephrectomy at a higher cost. 
  • Sirolimus monotherapy following Campath-1H induction. 
  • Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study. 
  • Solid organ transplantation at the National Institutes of Health: development of a research-based transplantation practice. 
  • Solid organ transplantation in primary mitochondrial disease: Proceed with caution. 
  • Solitary pancreas transplantation: experience with 50 consecutive cases. 
  • Source of Post-Transplant Care and Mortality among Kidney Transplant Recipients Dually Enrolled in VA and Medicare. 
  • Spectrum of disease in familial focal and segmental glomerulosclerosis. 
  • Spiral (helical) CT of the renal vasculature. 
  • Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection. 
  • Split tolerance induced by immunotoxin in a rhesus kidney allograft model. 
  • State medicaid coverage, ESRD incidence, and access to care. 
  • Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease. 
  • Steering between Scylla and Charybdis: Picking out the optimum time of double-J stent removal following renal transplantation. 
  • Steps toward transplantation tolerance in the clinic. 
  • Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials. 
  • Strategies for minimizing immunosuppression in kidney transplantation. 
  • Striking a Balance in Simultaneous Heart Kidney Transplant: Optimizing Outcomes for All Wait-Listed Patients. 
  • Successful combined liver/kidney transplantation from a donor with Pompe disease. 
  • Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. 
  • Successful extrarenal transplantation from non-heart-beating donors. 
  • Successful renal transplantation in a patient with congenital generalized lipodystrophy: a case report. 
  • Successful renal transplantation in patients with chronic granulomatous disease. 
  • Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient. 
  • Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation. 
  • Surgical Dead End in a Renal Transplant Recipient Associated With a Rare Thrombohemorrhagic Syndrome. 
  • Surgical technique in transplantation: how much does it matter? 
  • Surgical techniques in right laparoscopic donor nephrectomy. 
  • Surgical transplant physical examination: correlation of renal resistance index and biopsy-proven chronic allograft nephropathy. 
  • Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine. 
  • Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. 
  • System for integrated adherence monitoring: real-time non-adherence risk assessment in pediatric kidney transplantation. 
  • Systemic Kidney Transplant Inequities for Black Individuals: Examining the Contribution of Racialized Kidney Function Estimating Equations. 
  • Systemic autoimmune nephritogenic components induce CSF-1 and TNF-alpha in MRL kidneys. 
  • T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. 
  • Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. 
  • Tailored use of belatacept in adolescent kidney transplantation. 
  • Tailoring the 'Perfect Fit' for Renal Transplant Recipients with End-stage Polycystic Kidney Disease: Indications and Timing of Native Nephrectomy. 
  • Targeting Calcium Release-activated Calcium Channel Is Not Sufficient to Prevent Rejection in Nonhuman Primate Kidney Transplantation. 
  • Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients. 
  • Temporal Trends and Evolving Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US SLKT Consortium. 
  • Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation. 
  • The Clinical Impact of Non-HLA Antibodies in Solid Organ Transplantation. 
  • The Effect of Psychiatric History on Pain and Related Outcomes Among Living Kidney Donors. 
  • The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis. 
  • The Paradox of Increasing Waiting List Mortality and Declining Utilization of Deceased Donor Grafts in Kidney Transplant. 
  • The Systemic Immune-Inflammation Index Predicts Clinical Outcomes in Kidney Transplant Recipients. 
  • The TALKS study to improve communication, logistical, and financial barriers to live donor kidney transplantation in African Americans: protocol of a randomized clinical trial. 
  • The Vexing Problem of Persistent Disparities in Kidney Transplant Care. 
  • The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. 
  • The allocation of cadaver kidneys for transplantation in the United States: consensus and controversy. ASN Transplant Advisory Group. American Society of Nephrology. 
  • The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses. 
  • The association of state and national legislation with living kidney donation rates in the United States: a national study. 
  • The azaspirane SKF 105685 ameliorates renal allograft rejection in rats. 
  • The cam-path forward. 
  • The clinical application of monoclonal antibody therapies in renal transplantation. 
  • The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. 
  • The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge. 
  • The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. 
  • The effect of the Statewide Sharing variance on geographic disparity in kidney transplantation in the United States. 
  • The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells. 
  • The effects of donor-specific blood transfusion enhancement of rat renal allografts on host NK cell responses. 
  • The effects of surgery and acute rejection on glomerular hemodynamics in the transplanted rat kidney. 
  • The extent and predictors of waiting time geographic disparity in kidney transplantation in the United States. 
  • The fate of human platelets exposed to porcine renal endothelium: a single-pass model of platelet uptake in domestic and genetically modified porcine organs. 
  • The general public's concerns about clinical risk in live kidney donation. 
  • The history of human composite tissue allotransplantation. 
  • The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients. 
  • The impact of hypoalbuminemia in kidney-pancreas transplant recipients. 
  • The impact of morbid obesity on resource utilization after renal transplantation. 
  • The impact of septicemia occurring during hospitalization for renal transplantation procedures on outcomes in adults in United States. 
  • The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation. 
  • The impact of the host on fungal infections. 
  • The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients. 
  • The importance of class I and class II HLA in cadaveric renal transplantation. 
  • The incidence and management of pulmonary mycosis in renal allograft patients. 
  • The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. 
  • The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. 
  • The intragraft CD8+ T cell response in renal allograft rejection in the mouse. 
  • The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. 
  • The kidney in HIV infection: beyond HIV-associated nephropathy. 
  • The past, present, and future of costimulation blockade in organ transplantation. 
  • The problem of transplanting the sensitized patient: whose problem is it? 
  • The providing resources to enhance African American patients' readiness to make decisions about kidney disease (PREPARED) study: protocol of a randomized controlled trial. 
  • The rehabilitation of renal allograft recipients. 
  • The relationship between marijuana use and psychosocial variables in living kidney donor candidates. 
  • The relationship of transfusion and presensitization with graft and patient survival. 
  • The risk and opportunity of homeostatic repopulation. 
  • The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials. 
  • The role of MR imaging in the assessment of renal allograft vasculature. 
  • The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends. 
  • The source of murine cytomegalovirus in mice receiving kidney allografts. 
  • The spectrum of ciclosporin nephrotoxicity. 
  • The uneven distribution of kidney transplants: getting at the root causes and improving care. 
  • The use of UW solution in clinical transplantation. A 4-year experience. 
  • The use of bilateral adult renal allografts - a method to optimize function from donor kidneys with suboptimal nephron mass. 
  • The use of local allograft irradiation following renal transplantation. 
  • The use of spiral computed tomography in the evaluation of living donors for kidney transplantation. 
  • The utility of retroperitoneal kidney placement in simultaneous kidney pancreas transplantation. 
  • Therapeutic Drug Monitoring, Electronic Health Records, and Pharmacokinetic Modeling to Evaluate Sirolimus Drug Exposure-Response Relationships in Renal Transplant Patients. 
  • Therapeutic angiography in renal transplant complications. 
  • Therapeutic apheresis before and after kidney transplantation. 
  • Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine. 
  • Three-dimensional CT of the genitourinary tract. 
  • Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation. 
  • Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. 
  • Thrombus imaging with indium-111 platelets. 
  • Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). 
  • Timing and Number of Cutaneous Squamous Cell Carcinomas in Transplant Recipients. 
  • Tissue antigens of man and chimpanzees; their role in xenografting. 
  • Tolerance and near-tolerance strategies in monkeys and their application to human renal transplantation. 
  • Total lymphoid irradiation as an immunosuppressive agent for transplantation and the treatment of 'autoimmune' disease: a review. 
  • Tracking HLA Antibody Changes among Kidney Waitlist Candidates: One Protocol May Not Fit All. 
  • Transmission of cancer with cadaveric donor organs. 
  • Transmission of latent cytomegalovirus in a murine kidney tissue transplantation model. 
  • Transplant approach establishes that kidneys are responsible for serum CSF-1 but require a stimulus in MRL-lpr mice. 
  • Transplant social worker and donor financial assistance to increase living donor kidney transplants among African Americans: The TALKS Study, a randomized comparative effectiveness trial. 
  • Transplantation and autosomal recessive polycystic kidney disease. 
  • Transplantation and the end-stage renal disease program. 
  • Transplantation for polycystic kidney disease. 
  • Transplantation in miniature swine. VI. Factors influencing survival of renal allografts. 
  • Transplantation in the HIV+ patient. 
  • Transplanted carcinoma in an immunosuppressed patient. 
  • Transplanting the highly sensitized patient: trials and tribulations. 
  • Treatment strategies in renal carcinoma. 
  • Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. 
  • Treatment with immunotoxin. 
  • Trends in African Americans' Attitudes and Behaviors About Living Donor Kidney Transplantation. 
  • Tumor necrosis factor-alpha and tumor growth factor-beta1 genotype: partial association with intragraft gene expression in two cases of long-term peripheral tolerance to a kidney transplant. 
  • Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. 
  • Two rare forms of renal allograft glomerulopathy during cytomegalovirus infection and treatment. 
  • Type 2 angiotensin II receptor expression in human renal allografts: an association with chronic allograft nephropathy. 
  • Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. 
  • Understanding and overcoming barriers to living kidney donation among racial and ethnic minorities in the United States. 
  • Ureteroneocystostomy for renal transplantation. 
  • Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. 
  • Urinary obstruction in renal transplants: diagnosis by antegrade pyelography and results of percutaneous treatment. 
  • Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. 
  • Urine Metabolite Profiles Predictive of Human Kidney Allograft Status. 
  • Urine leaks after renal transplantation: value of percutaneous pyelography and drainage for diagnosis and treatment. 
  • Urine proteomics in kidney transplantation. 
  • Urologic complications in renal transplantation. 
  • Urologic complications in renal transplantation. 
  • Urologic morbidity in renal transplantation. 
  • Urologic surgery. 
  • Urological complications and vesicoureteral reflux following pediatric kidney transplantation. 
  • Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage. 
  • Usability of mobile technology to screen for drug-drug interactions in kidney transplant patients. 
  • Use of OKT3 in kidney, pancreas, and liver transplantation. 
  • Use of an inferior epigastic arterial catheter in a patient with difficult vascular access. 
  • Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. 
  • Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. 
  • Use of spiral computed tomography in the diagnosis of transplant renal artery stenosis. 
  • Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. 
  • Using renal transplantation to evaluate a simple approach for predicting the impact of end-stage renal disease therapies on patient survival: observed/expected life span. 
  • Utilization of pediatric donors for pancreas transplantation. 
  • Utilization of the chick chorioallantoic membrane for in vitro growth of the embryonic murine kidney. 
  • Utilization of the older donor for renal transplantation. 
  • Variables affecting the T cell receptor V beta repertoire heterogeneity of T cells infiltrating human renal allografts. 
  • Vascular Complications after Renal Transplantation: Another Brick in the Wall. 
  • Vascularized composite allotransplantation: a closer look at the banff working classification. 
  • Venous sinus thrombosis in a renal transplant patient. 
  • Viral infections after renal transplantation. 
  • West Nile virus-associated encephalitis in recipients of renal and pancreas transplants: case series and literature review. 
  • Why do secondary cadaver renal transplants succeed? Results of the South-Eastern Organ Procurement Foundation prospective study, 1977-1982. 
  • Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. 
  • Willingness of the United States general public to participate in kidney paired donation. 
  • Workshop on late renal allograft dysfunction. 
  • Xanthogranulomatous pyelonephritis in renal transplant recipient. 
• 

  Keywords of People

  • Boulware, L. Ebony, Adjunct Professor in the Department of Medicine, Duke Science & Society
  • Charles, Hal Cecil, Adjunct Associate Professor in the Department of Radiology, Radiology
  • Eleswarpu, Sarada, Assistant Professor of Anesthesiology, Anesthesiology, General, Vascular, High Risk Transplant & Critical Care
  • Kim, Charles Yoon, Professor of Radiology, Radiology, Interventional Radiology
  • Knechtle, Stuart Johnston, William R. Kenan, Jr. Distinguished Professor, Medicine, Nephrology
  • Lagoo, Anand Shreeram, Professor of Pathology, Pathology
  • Middleton, John Paul, Professor of Medicine, Medicine, Nephrology
  • Mohottige, Dinushika, Adjunct Assistant Professor in the Department of Medicine, Medicine, Nephrology
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Preminger, Glenn Michael, James F. Glenn, M.D. Distinguished Professor of Urology, Surgery, Urology
  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics